Television Viewing Time and Mortality. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab).
DW Dunstan,EL Barr,GN Healy,J Salmon,JE Shaw,B Balkau,DJ Magliano,AJ Cameron,PZ Zimmet,N Owen
Circulation 2010 1;():

A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).
DS Oyer,MD Shepherd,FC Coulter,A Bhargava,J Brett,PL Chu,BS Trippe
Am J Med 2009 11;122(11):1043-9

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
HW Rodbard,PS Jellinger,JA Davidson,D Einhorn,AJ Garber,G Grunberger,Y Handelsman,ES Horton,H Lebovitz,P Levy,ES Moghissi,SS Schwartz
Endocr Pract 2009 9;15(6):540-59

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.
M Jadzinsky,A Pfützner,E Paz-Pacheco,Z Xu,E Allen,R Chen
Diabetes Obes Metab 2009 6;11(6):611-22

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.
AR Chacra,GH Tan,A Apanovitch,S Ravichandran,J List,R Chen
Int J Clin Pract 2009 9;63(9):1395-406

Effects of Colesevelam HCl, Rosiglitazone, or Sitagliptin on Glycemic Control and the Lipid Profile in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy.
SP Rigby,Y Handelsman,YL Lai,SL Abby,B Tao,MR Jones
Endocr Pract 2009 9;():1-34

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
J Rosenstock,C Aguilar-Salinas,E Klein,S Nepal,J List,R Chen
Curr Med Res Opin 2009 10;25(10):2401-11

Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
KG Alberti,RH Eckel,SM Grundy,PZ Zimmet,JI Cleeman,KA Donato,JC Fruchart,WP James,CM Loria,SC Smith
Circulation 2009 10;():

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.
RA DeFronzo,MN Hissa,AJ Garber,J Luiz Gross,R Yuyan Duan,S Ravichandran,RS Chen
Diabetes Care 2009 9;32(9):1649-55